The document discusses the single-use tangential flow filtration (TFF) systems offered by Merck KGaA, specifically focusing on closed processing to minimize contamination risks and improve biopharmaceutical manufacturing efficiency. It outlines definitions, advantages, and the evolution toward fully closed systems, detailing components, processes, and performance testing of the TFF systems. The overall aim is to assure product integrity while facilitating faster production and reducing reliance on cleanroom environments.